Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Mimedx Group (MDXG) EPS (Basic): 2011-2024

Historic EPS (Basic) for Mimedx Group (MDXG) over the last 14 years, with Dec 2024 value amounting to $0.29.

  • Mimedx Group's EPS (Basic) rose 120.00% to $0.11 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.28, marking a year-over-year decrease of 54.84%. This contributed to the annual value of $0.29 for FY2024, which is 39.58% down from last year.
  • As of FY2024, Mimedx Group's EPS (Basic) stood at $0.29, which was down 39.58% from $0.48 recorded in FY2023.
  • In the past 5 years, Mimedx Group's EPS (Basic) registered a high of $0.48 during FY2023, and its lowest value of -$0.77 during FY2020.
  • For the 3-year period, Mimedx Group's EPS (Basic) averaged around $0.15, with its median value being $0.29 (2024).
  • As far as peak fluctuations go, Mimedx Group's EPS (Basic) crashed by 220.83% in 2020, and later soared by 245.45% in 2023.
  • Yearly analysis of 5 years shows Mimedx Group's EPS (Basic) stood at -$0.77 in 2020, then spiked by 77.92% to -$0.17 in 2021, then tumbled by 94.12% to -$0.33 in 2022, then soared by 245.45% to $0.48 in 2023, then slumped by 39.58% to $0.29 in 2024.